Evidence map›Paper›PMID 32703253›Full record

ReviewJournal of hematology & oncology2020

Crosstalks between inflammasome and autophagy in cancer.

Chaeuk Chung, Wonhyoung Seo, Prashanta Silwal, Eun-Kyeong Jo

Abstract readReview
In one paragraph

Review in Journal of hematology & oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed.

  1. Review
  2. Article
  3. Autophagy in Melanoma: Molecular Mechanisms and Therapeutic Perspectives.International journal of molecular sciences · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Piperine alleviates retinal ischemic injury by mediating the APE1 signaling.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Inflammasomes and autophagy in cancer: unlocking targeted therapies.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  15. Review
  16. Article
  17. Autophagy in cholangiocarcinoma: a comprehensive review about roles and regulatory mechanisms.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  18. Article
  19. Article
  20. Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chaeuk ChungDivision of Pulmonary and Critical Care, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, 35015, Korea.
Wonhyoung SeoInfection Control Convergence Research Center, Chungnam National University School of Medicine, Daejeon, 35015, Korea.
Prashanta SilwalInfection Control Convergence Research Center, Chungnam National University School of Medicine, Daejeon, 35015, Korea.
Eun-Kyeong JoInfection Control Convergence Research Center, Chungnam National University School of Medicine, Daejeon, 35015, Korea. hayoungj@cnu.ac.kr.ORCID 0000-0001-7191-0587

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Both inflammasomes and autophagy have important roles in the intracellular homeostasis, inflammation, and pathology; the dysregulation of these processes is often associated with the pathogenesis of numerous cancers. In addition, they can crosstalk with each other in multifaceted ways to influence various physiological and pathological responses, including cancer. Multiple molecular mechanisms connect the autophagy pathway to inflammasome activation and, through this, may influence the outcome of pro-tumor or anti-tumor responses depending on the cancer types, microenvironment, and the disease stage. In this review, we highlight the rapidly growing literature on the various mechanisms by which autophagy interacts with the inflammasome pathway, to encourage additional applications in the context of tumors. In addition, we provide insight into the mechanisms by which pathogen modulates the autophagy-inflammasome pathway to favor the infection-induced carcinogenesis. We also explore the challenges and opportunities of using multiple small molecules/agents to target the autophagy/inflammasome axis and their effects upon cancer treatment. Finally, we discuss the emerging clinical efforts assessing the potential usefulness of targeting approaches for either autophagy or inflammasome as anti-cancer strategies, although it remains underexplored in terms of their crosstalks.

Indexed as

AnimalsAutophagyClinical Trials as TopicHomeostasisHumansInflammasomesIntracellular MembranesMitochondriaMitophagyModels, BiologicalNeoplasm ProteinsNeoplasmsNLR Family, Pyrin Domain-Containing 3 ProteinReactive Oxygen SpeciesRNA, Double-StrandedRNA, NeoplasmInflammasomesNeoplasm ProteinsNLR Family, Pyrin Domain-Containing 3 ProteinReactive Oxygen SpeciesRNA, Double-StrandedRNA, NeoplasmAutophagyCancerInflammasomeMitochondrial ROSMitophagy

Identifiers

PMID32703253
PMCPMC7376907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.